ClinicalTrials.gg
Not yet recruitingNCT07926204Updated Nov 9, 2026

Functional Massage Versus Passive Mobilization After Total Knee Replacement

An interventional study of Functional Massage According to Olaf Evjenth and Passive Manual Knee Mobilization in Recovery After Total Knee Arthroplasty, sponsored by Azienda Ospedaliera Universitaria Integrata Verona. Not yet recruiting at 1 site in Italy. Open to participants aged 18 Years to 79 Years. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Azienda Ospedaliera Universitaria Integrata Verona · Not applicable, Interventional, and Treatment

Updated Nov 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 79 Years
Sex
All
01

Study summary

This study compares two physiotherapy treatments to help adults recover movement after total knee replacement: functional massage and passive knee mobilization. The main question is whether functional massage helps patients bend their knee further by the time they leave the acute hospital ward.

Forty adults undergoing replacement of one knee or both knees during the same operation will be randomly assigned to one of two groups. One group will receive functional massage according to Olaf Evjenth, and the other will receive passive manual knee mobilization. Both groups will also receive the same standard rehabilitation and pain management.

The assigned treatment will be provided once daily, starting on the first day after surgery and continuing until hospital discharge. Each treatment will last 10 minutes per operated knee.

A clinician who does not know which treatment the patient received will assess knee movement. The study will also evaluate pain, functional mobility, patient-reported outcomes, and length of hospital stay.

Read the detailed description

This is a single-center, randomized, parallel-group superiority trial comparing two manual physiotherapy approaches during the acute phase after total knee arthroplasty.

An independent researcher will generate the random allocation sequence. Allocation will be concealed using sequentially numbered, opaque, sealed envelopes, opened after eligibility has been confirmed and written informed consent obtained.

The primary analysis will follow the intention-to-treat principle. Passive knee flexion at discharge will be compared between groups using analysis of covariance, with baseline knee flexion as a covariate. For participants undergoing simultaneous bilateral total knee arthroplasty, one knee will be randomly selected for the primary analysis. A sensitivity analysis using mixed-effects models will account for paired knee measurements. Exploratory analyses will compare treatment effects in participants undergoing unilateral and simultaneous bilateral surgery.

Discharge timing depends on the availability of a bed in an inpatient rehabilitation facility rather than on predefined functional recovery thresholds.

02

Conditions studied

  • Recovery After Total Knee Arthroplasty

Keywords

  • Total Knee Arthroplasty
  • Physiotherapy
  • Functional Massage
  • Passive Mobilization
  • Postoperative Rehabilitation
03

In context

Lead sponsor

Azienda Ospedaliera Universitaria Integrata Verona is the lead sponsor of 95 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 79 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male and female patients aged 18 to 79 years.
  • Scheduled for elective primary total knee arthroplasty, either unilateral or simultaneous bilateral.
  • Ability to understand the nature of the study and provide written .

Exclusion criteria

Exclusion Criteria:

  • Revision total knee arthroplasty.
  • Age 80 years or older.
  • Severe comorbidities that could interfere with participation in the rehabilitation protocol or outcome assessment, including severe heart failure, severe , severe obesity with greater than 40 kg/m², or neurological conditions with significant motor deficits.
  • Cognitive deficits that prevent understanding and signing the or active participation in rehabilitation.
  • Total knee arthroplasty performed for non-degenerative causes, such as acute trauma or tumors.
  • Concomitant participation in another interventional clinical trial.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Functional Massage

    Participants receive functional massage according to Olaf Evjenth once daily from postoperative day 1 until hospital discharge, together with standardized pain management, assisted walking, and strengthening exercises.

    Other: Functional Massage According to Olaf Evjenth

  • Active comparator
    Passive Manual Mobilization

    Participants receive passive manual knee mobilization once daily from postoperative day 1 until hospital discharge, together with standardized pain management, assisted walking, and strengthening exercises.

    Other: Passive Manual Knee Mobilization

Interventions

  • OtherFunctional Massage According to Olaf Evjenth

    Functional massage of the anterior thigh with passive or active-assisted knee flexion, performed with the patient seated. Treatment lasts 10 minutes per operated knee, once daily, from postoperative day 1 until hospital discharge.

  • OtherPassive Manual Knee Mobilization

    Passive manual knee flexion and extension in the sagittal plane, performed with the patient supine. Treatment lasts 10 minutes per operated knee, once daily, from postoperative day 1 until hospital discharge.

06

What researchers measure

Primary outcomes

  1. Knee Flexion

    Passive knee flexion is measured in degrees using a standard goniometer, with the assessor moving the knee. Measurements are collected daily from postoperative day 1 until hospital discharge

    Time frame: Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

Secondary outcomes

  1. Pain Intensity

    Pain intensity is assessed using a Visual Analogue Scale and recorded on a 0-10 scale, with higher scores indicating greater pain. Measurements are collected at baseline and daily after each rehabilitation session from postoperative day 1 until hospital discharge, including the discharge day. Each daily measurement is recorded separately.

    Time frame: At baseline and daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

  2. Timed Up and Go Test

    Time in seconds required to stand up, walk 3 meters, turn, walk back, and sit down. The test is performed daily after the rehabilitation session from postoperative day 1 until hospital discharge, including the discharge day. Shorter times indicate better functional mobility. Each daily measurement is recorded separately.

    Time frame: Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

  3. Length of Hospital Stay

    Number of days from admission to the acute hospital ward until discharge

    Time frame: At discharge from the acute hospital ward, typically 5-7 days after surgery.

  4. Oxford Knee Score on Postoperative Day 1

    The Oxford Knee Score is a 12-item questionnaire assessing knee pain and difficulties with everyday activities over the previous four weeks. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating less pain and better function.

    Time frame: Postoperative day 1.

  5. Oxford Knee Score at Hospital Discharge

    The Oxford Knee Score is a 12-item questionnaire assessing knee pain and difficulties with everyday activities over the previous four weeks. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating less pain and better function.

    Time frame: At discharge from the acute hospital ward, typically 5-7 days after surgery.

  6. Oxford Knee Score at 1 Month

    The Oxford Knee Score is a 12-item questionnaire assessing knee pain and difficulties with everyday activities over the previous four weeks. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating less pain and better function. The questionnaire is administered by telephone interview.

    Time frame: 1 month after surgery

  7. Oxford Knee Score at 3 Months

    The Oxford Knee Score is a 12-item questionnaire assessing knee pain and difficulties with everyday activities over the previous four weeks. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating less pain and better function. The questionnaire is administered by telephone interview.

    Time frame: 3 months after surgery

  8. EQ-5D-5L Utility Index at day 1

    The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, from no problems to extreme problems or inability to perform the activity. Responses are converted into a health utility index using a country-specific value set. Higher index values indicate better health-related quality of life

    Time frame: Postoperative day 1.

  9. EQ-5D-5L Utility Index at discharge

    The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, from no problems to extreme problems or inability to perform the activity. Responses are converted into a health utility index using a country-specific value set. Higher index values indicate better health-related quality of life.

    Time frame: At discharge from the acute hospital ward, typically 5-7 days after surgery.

  10. EQ-5D-5L Utility Index at 1 Month

    The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, from no problems to extreme problems or inability to perform the activity. Responses are converted into a health utility index using a country-specific value set. Higher index values indicate better health-related quality of life. The questionnaire is administered by telephone

    Time frame: 1 month after surgery

  11. EQ-5D-5L Utility Index at 3 Months

    The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, from no problems to extreme problems or inability to perform the activity. Responses are converted into a health utility index using a country-specific value set. Higher index values indicate better health-related quality of life. The questionnaire is administered by telephone

    Time frame: 3 months after surgery

  12. EQ VAS on Postoperative Day 1

    Participants rate their overall health today on a scale from 0 (the worst health they can imagine) to 100 (the best health they can imagine). Higher scores indicate better self-rated health.

    Time frame: On postoperative day 1.

  13. EQ VAS at Hospital Discharge

    Participants rate their overall health today on a scale from 0 (the worst health they can imagine) to 100 (the best health they can imagine). Higher scores indicate better self-rated health.

    Time frame: At hospital discharge, typically 5-7 days after surgery.

  14. EQ VAS at 1 Month

    Participants rate their overall health today on a scale from 0 (the worst health they can imagine) to 100 (the best health they can imagine). Higher scores indicate better self-rated health.The assessment is administered by telephone

    Time frame: At 1 month after surgery.

  15. EQ VAS at 3 Months

    Participants rate their overall health today on a scale from 0 (the worst health they can imagine) to 100 (the best health they can imagine). Higher scores indicate better self-rated health. The assessment is administered by telephone

    Time frame: At 3 months after surgery.

Other outcomes

  1. Walking Distance During Assisted Ambulation

    Distance walked during assisted ambulation, measured in meters and recorded daily after the rehabilitation session.

    Time frame: Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

07

Study locations

1 site
  • Azienda Ospedaliera Universitaria Integrata Verona - U.O.C. Ortopedia, Ospedale Chirurgico Confortini
    Verona, Verona 37126, Italy
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for May 2028, 18 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 3, 2026
First posted
Nov 9, 2026
StartEst.
Nov 24, 2026
Primary completionEst.
May 2028
CompletionEst.
Aug 2028
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07926204
Lead sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Responsible party
Sponsor
First posted
Nov 9, 2026
Start date
Nov 24, 2026 (estimated)
Primary completion
May 2028 (estimated)
Completion
Aug 2028 (estimated)
Last update
Nov 9, 2026

Study contacts

Simone Patuzzo, Physiotherapist
Contact
simone.patuzzo@aovr.veneto.it
+393408117670
Simone Patuzzo
principal investigator · Azienda Ospedaliera Universitaria Integrata Verona

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion